N'-[(1E)-[4-(Benzyloxy)phenyl]methylidene]-2-cyanoacetohydrazide

Catalog No. :
ACMICV309
CAS No. :
339100-46-8
Molecular Formula :
C17H15N3O2
Molecular Weight :
293.33

IUPAC Name:(E)-N'-(4-(benzyloxy)benzylidene)-2-cyanoacetohydrazide

N'-[(1E)-[4-(Benzyloxy)phenyl]methylidene]-2-cyanoacetohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg90%$127.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-[(1E)-[4-(Benzyloxy)phenyl]methylidene]-2-cyanoacetohydrazide
IUPAC Name(E)-N'-(4-(benzyloxy)benzylidene)-2-cyanoacetohydrazide
MDL No.MFCD00664648
Molecular FormulaC17H15N3O2
Molecular Weight293.33
SMILESO=C(N/N=C/C1=CC=C(OCC2=CC=CC=C2)C=C1)CC#N
InChI KeyCCYRDRJXORZVCA-XDHOZWIPSA-N
SynonymN'-([4-(BENZYLOXY)PHENYL]METHYLENE)-2-CYANOACETOHYDRAZIDE;N'-[(1E)-[4-(benzyloxy)phenyl]methylidene]-2-cyanoacetohydrazide;(E)-N'-(4-(benzyloxy)benzylidene)-2-cyanoacetohydrazide;Acetic acid, 2-cyano-, 2-[[4-(phenylmethoxy)phenyl]methylene]hydrazide
CAS No.339100-46-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMICV309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDNZY062 route compound structure diagram
    ACDNZY0624397-53-9 In Stock
  4. Then
  5. ACMICV309 route product structure diagram
    ACMICV309339100-46-8
Inquiry

2. ACMICV309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMCAP915 route compound structure diagram
    ACMCAP9151071-36-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMICV309 route product structure diagram
    ACMICV309339100-46-8
Inquiry

Comments (0)